Change in vision (particularly in those with diabetic retinopathy) Hypoglycemia (low blood sugar) dizziness or light-headedness, sweating, shakiness, blurred vision, slurred speech, weakness, anxiety, hunger, headache, irritability or mood changes, confusion or drowsiness, fast heartbeat, or feeling jittery
Researchers should consult primary literature on Ipamorelin and CJC-1295 (modified GRF 1-29) for study-specific protocols and concentrations
For more information, contact us at Medrein Health & Aesthetics today.
Wegovy vs Ozempic: Which is Right for You
The central nervous system inflammatory response to neurotropic virus infection is peroxynitrite dependent